Zou W, Zhou Y, Yao J, Feng B, Xiong D, Chen C
Eur Radiol. 2025; .
PMID: 39903238
DOI: 10.1007/s00330-025-11386-7.
Peng H, Zheng M, Li J, Jin Z
Transl Cancer Res. 2024; 13(8):4278-4289.
PMID: 39262486
PMC: 11384314.
DOI: 10.21037/tcr-24-247.
Ito Y, Miyauchi A
Eur Thyroid J. 2024; 13(5).
PMID: 39213599
PMC: 11466271.
DOI: 10.1530/ETJ-24-0196.
Sahin C, Inan M, Bilezikci B, Bostanci H, Taneri F, Kozan R
Diagnostics (Basel). 2024; 14(15).
PMID: 39125500
PMC: 11311513.
DOI: 10.3390/diagnostics14151624.
Ju S, Ji Y, Song M, Lim J, Heo D, Kim M
Eur Thyroid J. 2024; 13(2).
PMID: 38484463
PMC: 11046321.
DOI: 10.1530/ETJ-23-0258.
Relationship between the Expression of CHK2 and p53 in Tumor Tissue and the Course of Papillary Thyroid Cancer in Patients with Germline Mutations.
Gasior-Perczak D, Kowalik A, Kopczynski J, Macek P, Niemyska K, Walczyk A
Cancers (Basel). 2024; 16(4).
PMID: 38398207
PMC: 10886656.
DOI: 10.3390/cancers16040815.
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up.
Marongiu A, Nuvoli S, De Vito A, Vargiu S, Spanu A, Madeddu G
Biomedicines. 2024; 12(2).
PMID: 38397952
PMC: 10886778.
DOI: 10.3390/biomedicines12020350.
Risk factors associated with high-risk nodal disease in patients considered for active surveillance of papillary thyroid microcarcinoma without extrathyroidal extension.
Kwon O, Lee S, Bae J
Gland Surg. 2023; 12(9):1179-1190.
PMID: 37842526
PMC: 10570983.
DOI: 10.21037/gs-23-256.
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis.
Russo E, Guizzardi M, Canali L, Gaino F, Costantino A, Mazziotti G
Rev Endocr Metab Disord. 2023; 24(6):1205-1216.
PMID: 37828383
DOI: 10.1007/s11154-023-09845-x.
Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients.
Al-Ibraheem A, Al-Rasheed U, Mashhadani N, Abdlkadir A, Al-Adhami D, Ruzzeh S
Cancers (Basel). 2023; 15(16).
PMID: 37627130
PMC: 10452119.
DOI: 10.3390/cancers15164102.
Clinical, cytological and ultrasonographic features of incidental thyroid cancer in a hospital-based study in vietnam.
Quang Nguyen B, Tran H, Nguyen H, Nguyen T, Nguyen T, Nguyen T
Endocrinol Diabetes Metab. 2023; 6(3):e415.
PMID: 36896571
PMC: 10164435.
DOI: 10.1002/edm2.415.
A nomogram for predicting overall survival in patients with follicular thyroid cancer after thyroidectomy: a SEER database analysis.
Wang C, Wu X, Chen H, Le Q, Dai L
Gland Surg. 2022; 11(8):1356-1366.
PMID: 36082104
PMC: 9445705.
DOI: 10.21037/gs-22-386.
Long-Term Outcome of Differentiated Thyroid Cancer Patients-Fifty Years of Croatian Thyroid Disease Referral Centre Experience.
Jukic T, Blazekovic I, Franceschi M, Petranovic Ovcaricek P, Bosak Butkovic M, Dabelic N
Diagnostics (Basel). 2022; 12(4).
PMID: 35453913
PMC: 9025554.
DOI: 10.3390/diagnostics12040866.
Clinicopathological features and prognosis of papillary thyroid cancer patients with type 2 diabetes mellitus.
Shi P, Zhang L, Liu Y, Yang F, Fu K, Li R
Gland Surg. 2022; 11(2):358-368.
PMID: 35284317
PMC: 8899419.
DOI: 10.21037/gs-21-905.
Variations in Radioiodine Therapy in Europe: Decision-Making after Total Thyroidectomy.
Forrer F, Fischer G, Maas O, Giovanella L, Hoffmann M, Iakovou I
Oncology. 2021; 100(2):74-81.
PMID: 34788758
PMC: 8985029.
DOI: 10.1159/000520938.
Risk factors associated with disease-specific mortality in papillary thyroid cancer patients with distant metastases.
Nunes K, Matos L, Cavalheiro B, Magnabosco F, Tavares M, Kulcsar M
Endocrine. 2021; 75(3):814-822.
PMID: 34665427
DOI: 10.1007/s12020-021-02901-z.
Does macroscopic extrathyroidal extension to the strap muscles alone affect survival in papillary thyroid carcinoma?.
Harries V, McGill M, Yuan A, Wang L, Tuttle R, Shaha A
Surgery. 2021; 171(5):1341-1347.
PMID: 34600743
PMC: 8960478.
DOI: 10.1016/j.surg.2021.08.041.
Comparison of the abilities of staging and risk stratification systems to predict the long-term structural recurrence in patients with differentiated thyroid carcinoma after total thyroidectomy and radioactive iodine remnant ablation.
Nam K, Park J, Moon G, Yoon J
Gland Surg. 2021; 10(7):2200-2210.
PMID: 34422591
PMC: 8340347.
DOI: 10.21037/gs-21-8.
Radiomics based on multiparametric MRI for extrathyroidal extension feature prediction in papillary thyroid cancer.
Wei R, Wang H, Wang L, Hu W, Sun X, Dai Z
BMC Med Imaging. 2021; 21(1):20.
PMID: 33563233
PMC: 7871407.
DOI: 10.1186/s12880-021-00553-z.
Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer.
Alzahrani A, Moria Y, Mukhtar N, Aljamei H, Mazi S, Albalawi L
J Endocr Soc. 2020; 5(1):bvaa178.
PMID: 33367194
PMC: 7745668.
DOI: 10.1210/jendso/bvaa178.